Sustained-release formulation of methylphenidate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5874090
SERIAL NO

08679875

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The subject invention pertains to a sustained-release formulation of d-threo-methylphenidate (dtmp). The subject invention also pertains to methods for treating disorders using a sustained-release formulation comprising d-threo-methylphenidate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLTECH PHARMA EUROPE LIMITED208 BATH ROAD SLOUGH BERKSHIRE SL1 3WE

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baker, Helen Frances Cambridge, GB 5 164
Gilbert, Julian Clive Cambridge, GB 30 321

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation